Circulating mitochondrial DNA as a biomarker for lung cancer screening.
作者信息
von Itzstein Mitchell S, Gerber David E, Minna John D
机构信息
Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Hamon Center for Therapeutic Oncology Research and the Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.
出版信息
Transl Lung Cancer Res. 2022 Aug;11(8):1522-1525. doi: 10.21037/tlcr-22-511.
Abstract
摘要
相似文献
1
Circulating mitochondrial DNA as a biomarker for lung cancer screening.循环线粒体DNA作为肺癌筛查的生物标志物
Transl Lung Cancer Res. 2022 Aug;11(8):1522-1525. doi: 10.21037/tlcr-22-511.
2
The level of free-circulating mtDNA in patients with radon-induced lung cancer.氡致肺癌患者体内游离循环线粒体DNA的水平。
Environ Res. 2022 May 1;207:112215. doi: 10.1016/j.envres.2021.112215. Epub 2021 Oct 14.
3
Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.循环血浆DNA作为非小细胞肺癌的诊断生物标志物
Lung Cancer. 2009 Apr;64(1):92-7. doi: 10.1016/j.lungcan.2008.07.012. Epub 2008 Sep 19.
4
Value of quantitative analysis of circulating cell free DNA as a screening tool for lung cancer: a meta-analysis.循环游离 DNA 定量分析作为肺癌筛查工具的价值：一项荟萃分析。
Lung Cancer. 2010 Aug;69(2):225-31. doi: 10.1016/j.lungcan.2009.11.009. Epub 2009 Dec 11.
5
A systematic review and meta-analysis of circulating cell-free DNA as a diagnostic biomarker for non-small cell lung cancer.循环游离DNA作为非小细胞肺癌诊断生物标志物的系统评价与荟萃分析。
J Thorac Dis. 2022 Jun;14(6):2103-2111. doi: 10.21037/jtd-22-646.
6
Liquid biopsy for lung cancer screening: Usefulness of circulating tumor cells and other circulating blood biomarkers.液体活检在肺癌筛查中的应用：循环肿瘤细胞和其他循环血液生物标志物的作用。
Cancer Cytopathol. 2021 May;129(5):341-346. doi: 10.1002/cncy.22367. Epub 2020 Oct 2.
7
Circulating mitochondria DNA, a non-invasive cancer diagnostic biomarker candidate.循环线粒体 DNA，一种非侵入性癌症诊断生物标志物候选物。
Mitochondrion. 2019 Jul;47:238-243. doi: 10.1016/j.mito.2018.12.003. Epub 2018 Dec 16.
8
Biomarkers in Lung Cancer Screening: a Narrative Review.肺癌筛查中的生物标志物：一篇叙述性综述。
Curr Chall Thorac Surg. 2023 Feb 25;5. doi: 10.21037/ccts-20-171. Epub 2021 Mar 1.
9
Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study.循环肿瘤细胞作为肺癌筛查的潜在生物标志物：一项前瞻性队列研究。
Lancet Respir Med. 2020 Jul;8(7):709-716. doi: 10.1016/S2213-2600(20)30081-3.
10
Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies.血清中循环的线粒体 DNA：泌尿系统恶性肿瘤患者的通用诊断生物标志物。
Urol Oncol. 2012 Jul-Aug;30(4):509-15. doi: 10.1016/j.urolonc.2010.03.004. Epub 2010 Sep 26.
本文引用的文献
1
Peripheral blood leukocyte mitochondrial DNA content and risk of lung cancer.外周血白细胞线粒体DNA含量与肺癌风险
Transl Lung Cancer Res. 2022 Jul;11(7):1268-1278. doi: 10.21037/tlcr-21-979.
2
The longitudinal dynamics and natural history of clonal haematopoiesis.克隆性造血的纵向动力学和自然史。
Nature. 2022 Jun;606(7913):335-342. doi: 10.1038/s41586-022-04785-z. Epub 2022 Jun 1.
3
Contemporary Lung Cancer Screening and the Promise of Blood-Based Biomarkers.当代肺癌筛查与基于血液的生物标志物的前景。
Cancer Res. 2021 Jul 1;81(13):3441-3443. doi: 10.1158/0008-5472.CAN-21-0706.
4
Early Diagnosis and Screening for Lung Cancer.肺癌的早期诊断和筛查。
Cold Spring Harb Perspect Med. 2021 Sep 1;11(9):a037994. doi: 10.1101/cshperspect.a037994.
5
Rare deleterious germline variants and risk of lung cancer.罕见有害生殖系变异与肺癌风险
NPJ Precis Oncol. 2021 Feb 16;5(1):12. doi: 10.1038/s41698-021-00146-7.
6
Application of Radiomics and Artificial Intelligence for Lung Cancer Precision Medicine.放射组学和人工智能在肺癌精准医学中的应用。
Cold Spring Harb Perspect Med. 2021 Aug 2;11(8):a039537. doi: 10.1101/cshperspect.a039537.
7
Protein-altering germline mutations implicate novel genes related to lung cancer development.胚系致病变异蛋白与肺癌发生相关的新基因。
Nat Commun. 2020 May 11;11(1):2220. doi: 10.1038/s41467-020-15905-6.
8
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.随机试验中 CT 容积筛查降低肺癌死亡率
N Engl J Med. 2020 Feb 6;382(6):503-513. doi: 10.1056/NEJMoa1911793. Epub 2020 Jan 29.
9
Increasing Numbers and Reported Adverse Events in Patients with Lung Cancer Undergoing Inpatient Lung Biopsies: A Population-Based Analysis.肺癌患者接受住院肺活检的数量和报告的不良事件不断增加：一项基于人群的分析。
Lung. 2019 Oct;197(5):593-599. doi: 10.1007/s00408-019-00255-y. Epub 2019 Jul 31.
10
Lung Cancer Screening Utilization: A Behavioral Risk Factor Surveillance System Analysis.肺癌筛查利用：行为风险因素监测系统分析。
Am J Prev Med. 2019 Aug;57(2):250-255. doi: 10.1016/j.amepre.2019.03.015. Epub 2019 Jun 24.
Zotero 插件